Showing posts with label limbach. Show all posts
Showing posts with label limbach. Show all posts

Friday, May 31, 2013

Disruptive Innovation in R&D Processes

In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D.

Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development

Tuesday, April 30, 2013

Developing Robust Potency Assays for Validation

In this episode, Peter Wunderli, Ph.D., discusses PPD's recent laboratory facility expansion, outlines challenges and critical factors in cell-based bio bioassay product development, talks about disease states suitable for this type of technology, and finally, takes a look into the future of cell-based assays.

Thought Leader: Peter Wunderli, Ph.D., Associate Director, Biopharmaceutical Services at PPD

What is Creativity?

In this episode, Anthony Rotolo talks about creativity in the health and wellness space. We cover the importance of creativity in advertising, how to be creative, and, when used properly, how creativity influences behavior change.

Thought Leader: Anthony Rotolo, Chief Creative Officer, TRUE Health + Wellness

Thursday, January 31, 2013

Conducting User Testing to Improve Clinical Trial Technologies

Thought Leader: Joseph Bedford, Ph.D., Director of Marketing, Almac Clinical Technologies

In this episode, we discuss how user testing research improves the clinical trial process for patients, sites, and sponsors.

For more information about Almac Clinical Technologies, visit www.almacgroup.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thursday, April 30, 2009

Better Standards and Metrics for CROs and Sponsors

Date:4/08/2009
Length: 00:14:29
Size: 6.63MB
Thought Leaders:
Gregg Dearhammer, President, i3 Statprobe
Karen Goss, Global Director, Pharmacovigilance, i3 Drug Safety

In this episode, Mr. Dearhammer and Ms. Goss discuss the need for metrics and standards for clinical trials management and the impact of the Metrics Champion Consortium (MCC) on CROs and sponsors.

Play podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Thursday, April 02, 2009

Setting Sail for Success by Optimizing Productivity

Date:4/01/2009
Length: 00:14:31
Size: 6.64MB

Thought Leaders: Michael Hagan, Principal Consultant, Quintiles Consulting and James C. Kirk, VP and Practice Leader, Eidetics, Quintiles Consulting

In episode one, of a three-part series, “Surviving to Thriving in Stormy Weather,” Mr. Hagan and Mr. Kirk discuss market pressures and how economic turmoil in the biopharma industry can be overcome by using process optimization.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157